IL143671A0 - PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF BREAST CANCER COMPRISING hCG - Google Patents

PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF BREAST CANCER COMPRISING hCG

Info

Publication number
IL143671A0
IL143671A0 IL14367199A IL14367199A IL143671A0 IL 143671 A0 IL143671 A0 IL 143671A0 IL 14367199 A IL14367199 A IL 14367199A IL 14367199 A IL14367199 A IL 14367199A IL 143671 A0 IL143671 A0 IL 143671A0
Authority
IL
Israel
Prior art keywords
hcg
treatment
pharmaceutical compositions
breast cancer
breast
Prior art date
Application number
IL14367199A
Other languages
English (en)
Original Assignee
Fox Chase Cancer Ct
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fox Chase Cancer Ct, Applied Research Systems filed Critical Fox Chase Cancer Ct
Publication of IL143671A0 publication Critical patent/IL143671A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL14367199A 1998-12-15 1999-12-15 PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF BREAST CANCER COMPRISING hCG IL143671A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98123817A EP1013281A1 (de) 1998-12-15 1998-12-15 hCG Therapie für Behandlung von Brustkrebs
PCT/US1999/029795 WO2000035469A2 (en) 1998-12-15 1999-12-15 hCG THERAPY FOR THE TREATMENT OF BREAST CANCER

Publications (1)

Publication Number Publication Date
IL143671A0 true IL143671A0 (en) 2002-04-21

Family

ID=8233138

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14367199A IL143671A0 (en) 1998-12-15 1999-12-15 PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF BREAST CANCER COMPRISING hCG
IL143671A IL143671A (en) 1998-12-15 2001-06-11 Pharmaceuticals for the treatment of breast cancer that contain GCH

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL143671A IL143671A (en) 1998-12-15 2001-06-11 Pharmaceuticals for the treatment of breast cancer that contain GCH

Country Status (16)

Country Link
US (1) US7183251B1 (de)
EP (2) EP1013281A1 (de)
JP (1) JP2003523311A (de)
AR (1) AR023726A1 (de)
AT (1) ATE353664T1 (de)
AU (1) AU781495B2 (de)
BR (1) BR9916221A (de)
CA (1) CA2351726A1 (de)
CY (1) CY1106525T1 (de)
DE (1) DE69935156T2 (de)
DK (1) DK1140147T3 (de)
ES (1) ES2277461T3 (de)
IL (2) IL143671A0 (de)
PT (1) PT1140147E (de)
SI (1) SI1140147T1 (de)
WO (1) WO2000035469A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2582567A1 (en) * 2004-10-07 2006-04-13 Stem Cell Therapeutics Corp. Stimulation of proliferation of pluripotential stem cells through administration of pregnancy associated compounds
US9332973B2 (en) 2008-10-01 2016-05-10 Covidien Lp Needle biopsy device with exchangeable needle and integrated needle protection
US9186128B2 (en) 2008-10-01 2015-11-17 Covidien Lp Needle biopsy device
US11298113B2 (en) 2008-10-01 2022-04-12 Covidien Lp Device for needle biopsy with integrated needle protection
US9782565B2 (en) 2008-10-01 2017-10-10 Covidien Lp Endoscopic ultrasound-guided biliary access system
US8968210B2 (en) 2008-10-01 2015-03-03 Covidien LLP Device for needle biopsy with integrated needle protection

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0160699B1 (de) 1983-11-02 1992-08-12 Applied Research Systems Ars Holding N.V. Herstellung heterodimerer menschlicher fruchtbarkeitshormone
US5677275A (en) 1994-08-05 1997-10-14 The United States Of America As Represented By The Department Of Health And Human Services Treatment of cancer with human chorionic gonadotropin
US5700781A (en) 1994-10-04 1997-12-23 Harris; Pamela Jo Method for treating Kaposi's sarcoma and HIV infections
US5997871A (en) * 1996-06-24 1999-12-07 University Of Maryland Biotechnology Insitute Treatment and prevention of cancer by administration of derivatives of human chorionic gonadotropin

Also Published As

Publication number Publication date
ATE353664T1 (de) 2007-03-15
ES2277461T3 (es) 2007-07-01
PT1140147E (pt) 2007-03-30
EP1140147A2 (de) 2001-10-10
DK1140147T3 (da) 2007-03-26
WO2000035469A9 (en) 2001-03-22
EP1013281A1 (de) 2000-06-28
SI1140147T1 (sl) 2007-06-30
AU2363100A (en) 2000-07-03
AR023726A1 (es) 2002-09-04
DE69935156D1 (de) 2007-03-29
DE69935156T2 (de) 2007-11-22
AU781495B2 (en) 2005-05-26
EP1140147B1 (de) 2007-02-14
WO2000035469A3 (en) 2000-09-14
JP2003523311A (ja) 2003-08-05
US7183251B1 (en) 2007-02-27
WO2000035469A2 (en) 2000-06-22
CA2351726A1 (en) 2000-06-22
IL143671A (en) 2009-08-03
BR9916221A (pt) 2001-09-11
CY1106525T1 (el) 2012-01-25

Similar Documents

Publication Publication Date Title
AU1807401A (en) Compositions and methods for therapy and diagnosis of breast cancer
HUP0201187A3 (en) Use of ecteinascidin743 for producing pharmaceutical compositions suitable for treating cancer
HUP0200763A2 (en) Compositions for the treatment and diagnosis of breast cancer and methods for their use
PL349322A1 (en) Compositions and methods for therapy and diagnosis of ovarian cancer
EP0942742A4 (de) Therapeutische zusammensetzungen zur krebsbehandlung
PL354540A1 (en) Drugs for the treatment of malignant tumours
PL365244A1 (en) Compositions and methods for the therapy and diagnosis of breast cancer
IL132287A0 (en) Compositions and methods for the treatment and diagnosis of breast cancer
KR100510795B1 (en) Compositions and Methods for the Treatment of Tumor
AU5160201A (en) Compositions comprising natural agents for treatment of cancer
AU3391200A (en) Compositions and methods for breast cancer therapy and diagnosis
HUP9701777A3 (en) Use of raloxifene for producing pharmaceutical compositions for preventing breast cancer
PL358542A1 (en) Exemestane for first-line treatment of breast cancer
HUP0402341A3 (en) Compositions containing thiazol-2-ylamines for the treatment of cancer
AU5638400A (en) Compositions and methods for the therapy and diagnosis of breast cancer
IL143671A0 (en) PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF BREAST CANCER COMPRISING hCG
ZA200108256B (en) Compositions and methods for the treatment and diagnosis of breast cancer.
HUP0200825A2 (en) Compositions and methods for the treatment and diagnosis of breast cancer
IL149281A0 (en) Treatment of cancer
GB9819999D0 (en) Treatment of cancer
HUP0203558A3 (en) Substituted pyrroles as antiproliferative compounds for the treatment of cancer and pharmaceutical compositions containing them
AU2292801A (en) Compositions and methods for treatment of breast cancer
AU2001280443A1 (en) Compositions and methods for the therapy and diagnosis of breast cancer
HUP9902840A3 (en) Use of lectin for producing pharmaceutical compositions suitable for treatment of cancer
IL138705A0 (en) Pharmaceutical compositions comprising erythropoietin for treatment of cancer